2-AAF-induced tumor development in nucleotide excision repair-deficient mice is associated with a defect in global genome repair but not with transcription coupled repair. 2005

Esther M Hoogervorst, and Conny Th M van Oostrom, and Rudolf B Beems, and Jan van Benthem, and Jolanda van den Berg, and Coen F van Kreijl, and Joseph G Vos, and Annemieke de Vries, and Harry van Steeg
Laboratory of Toxicology, Pathology and Genetics, National Institute of Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands.

The nucleotide excision repair (NER) pathway comprises two sub-pathways, transcription coupled repair (TCR) and global genome repair (GGR). To establish the importance of these separate sub-pathways in tumor suppression, we exposed mice deficient for either TCR (Csb), GGR (Xpc) or both (Xpa) to 300 ppm 2-acetylaminofluorene (in feed, ad libitum) in a unique comparative exposure experiment. We found that cancer proneness was directly linked to a defect in the GGR pathway of NER as both Xpa and Xpc mice developed significantly more liver tumors upon 2-AAF exposure than wild type or Csb mice. In contrast, a defect in TCR appeared to act tumor suppressive, leading to a lower hepatocellular tumor response in Xpa mice (tumor incidence of 25%) as compared to Xpc mice (53% tumor-bearing mice). The link between deficient GGR and tumor proneness was most pronounced in the liver, but this phenomenon was also found in the urinary bladder. As tumor induction by 2-AAF appeared almost exclusively dependent on a defect in GGR, we examined whether gene mutation induction in the non-transcribed lacZ locus could reliably predict tumor risk. Interestingly, however, short-term 2-AAF exposure induced lacZ mutant levels in Csb mice almost as high as those found in Xpa or Xpc mice. This indicates that lacZ mutant frequencies are not correlated with a specific DNA repair defect and eventual tumor outcome, at least not in the experimental design presented here.

UI MeSH Term Description Entries
D007763 Lac Operon The genetic unit consisting of three structural genes, an operator and a regulatory gene. The regulatory gene controls the synthesis of the three structural genes: BETA-GALACTOSIDASE and beta-galactoside permease (involved with the metabolism of lactose), and beta-thiogalactoside acetyltransferase. Lac Gene,LacZ Genes,Lactose Operon,Gene, Lac,Gene, LacZ,Genes, Lac,Genes, LacZ,Lac Genes,Lac Operons,LacZ Gene,Lactose Operons,Operon, Lac,Operon, Lactose,Operons, Lac,Operons, Lactose
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D015073 2-Acetylaminofluorene A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines. 2-Acetamidofluorene,Fluoren-2-ylacetamide,2-AAF,2-Fluorenylacetamide,AAF, Aminofluorene,Acetylaminofluorene,N-2-Fluorenylacetamide,N-Acetyl-2-Aminofluorene,2 Acetamidofluorene,2 Acetylaminofluorene,2 Fluorenylacetamide,Aminofluorene AAF,Fluoren 2 ylacetamide,N 2 Fluorenylacetamide,N Acetyl 2 Aminofluorene
D016678 Genome The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA. Genomes

Related Publications

Esther M Hoogervorst, and Conny Th M van Oostrom, and Rudolf B Beems, and Jan van Benthem, and Jolanda van den Berg, and Coen F van Kreijl, and Joseph G Vos, and Annemieke de Vries, and Harry van Steeg
December 1998, Mutation research,
Esther M Hoogervorst, and Conny Th M van Oostrom, and Rudolf B Beems, and Jan van Benthem, and Jolanda van den Berg, and Coen F van Kreijl, and Joseph G Vos, and Annemieke de Vries, and Harry van Steeg
January 2023, Journal of biosciences,
Esther M Hoogervorst, and Conny Th M van Oostrom, and Rudolf B Beems, and Jan van Benthem, and Jolanda van den Berg, and Coen F van Kreijl, and Joseph G Vos, and Annemieke de Vries, and Harry van Steeg
December 2001, Journal of photochemistry and photobiology. B, Biology,
Esther M Hoogervorst, and Conny Th M van Oostrom, and Rudolf B Beems, and Jan van Benthem, and Jolanda van den Berg, and Coen F van Kreijl, and Joseph G Vos, and Annemieke de Vries, and Harry van Steeg
October 1997, Nucleic acids research,
Esther M Hoogervorst, and Conny Th M van Oostrom, and Rudolf B Beems, and Jan van Benthem, and Jolanda van den Berg, and Coen F van Kreijl, and Joseph G Vos, and Annemieke de Vries, and Harry van Steeg
December 2014, Molecular cell,
Esther M Hoogervorst, and Conny Th M van Oostrom, and Rudolf B Beems, and Jan van Benthem, and Jolanda van den Berg, and Coen F van Kreijl, and Joseph G Vos, and Annemieke de Vries, and Harry van Steeg
April 2019, BioEssays : news and reviews in molecular, cellular and developmental biology,
Esther M Hoogervorst, and Conny Th M van Oostrom, and Rudolf B Beems, and Jan van Benthem, and Jolanda van den Berg, and Coen F van Kreijl, and Joseph G Vos, and Annemieke de Vries, and Harry van Steeg
February 2022, Nature communications,
Esther M Hoogervorst, and Conny Th M van Oostrom, and Rudolf B Beems, and Jan van Benthem, and Jolanda van den Berg, and Coen F van Kreijl, and Joseph G Vos, and Annemieke de Vries, and Harry van Steeg
October 2005, Cancer research,
Esther M Hoogervorst, and Conny Th M van Oostrom, and Rudolf B Beems, and Jan van Benthem, and Jolanda van den Berg, and Coen F van Kreijl, and Joseph G Vos, and Annemieke de Vries, and Harry van Steeg
October 2003, The Journal of investigative dermatology,
Esther M Hoogervorst, and Conny Th M van Oostrom, and Rudolf B Beems, and Jan van Benthem, and Jolanda van den Berg, and Coen F van Kreijl, and Joseph G Vos, and Annemieke de Vries, and Harry van Steeg
August 2023, The Journal of biological chemistry,
Copied contents to your clipboard!